Indeed, cDC1 are essential for the response to anti-immune checkpoints, such as anti-PD-L1, anti-CTLA4 and anti-CD137 [81,82,83], and to adoptive transfer of anti-tumor T cells [77,84], since treatment efficacy is lost in cDC1 deficient mice. This evidence concerns the gene MPPE1 and neoplasm.